Exclusive agreements between Federal agencies and Bristol-Myers Squibb Co. for drug development : is the public interest protected? : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, July 29, 1991., by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation

Title:	Exclusive agreements between Federal agencies and Bristol-Myers Squibb Co. for drug development : is the public interest protected? : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, July 29, 1991.
Author:	United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy
Note:	U.S. G.P.O. :, 1992

Link:	page images at HathiTrust
No stable link:	This is an uncurated book entry from our extended bookshelves, readable online now but without a stable link here. You should not bookmark this page, but you can request that we add this book to our curated collection, which has stable links.

Subject:	Administrative agencies -- United States
Subject:	Bristol-Myers Squibb Company
Subject:	Cancer -- Treatment -- Research -- United States
Subject:	Exclusive contracts -- United States
Subject:	Paclitaxel
Subject:	Yew -- Northwest, Pacific
Other copies:	Look for editions of this book at your library, or elsewhere.